These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 34889221)
1. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
2. Gene Signatures and Prognostic Value of m6A RNA Methylation Regulators in Uterine Corpus Endometrial Carcinoma. Feng Y; Yao C; Shen J; Zhou J Discov Med; 2021; 31(164):111-120. PubMed ID: 35188885 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma. Wang Y; Ren F; Song Z; Wang X; Ma X J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522 [TBL] [Abstract][Full Text] [Related]
5. m Fang F; Wang P; Huang H; Ye M; Liu X; Li Q BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Wu X; Zhang X; Tao L; Dai X; Chen P Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931 [TBL] [Abstract][Full Text] [Related]
7. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma. Zhang X; Pang X; Huang Y; Qian S Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma. Shen C; Liu J; Yang X; Jiao W; Wang Y Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753 [TBL] [Abstract][Full Text] [Related]
9. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma. Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782 [TBL] [Abstract][Full Text] [Related]
11. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327 [TBL] [Abstract][Full Text] [Related]
12. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma. Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J Front Immunol; 2021; 12():788431. PubMed ID: 34970268 [TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma. Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963 [TBL] [Abstract][Full Text] [Related]
14. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma. Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
16. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database. Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565 [TBL] [Abstract][Full Text] [Related]
17. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma. Li Z; Li F; Peng Y; Fang J; Zhou J Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856 [TBL] [Abstract][Full Text] [Related]
18. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521 [TBL] [Abstract][Full Text] [Related]
19. Identification of clinical prognostic features of esophageal cancer based on m6A regulators. Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y Front Immunol; 2022; 13():950365. PubMed ID: 36159855 [TBL] [Abstract][Full Text] [Related]
20. Cuproptosis-Associated lncRNA Gene Signature Establishes New Prognostic Profile and Predicts Immunotherapy Response in Endometrial Carcinoma. Jiang XY; Hu JJ; Wang R; Zhang WY; Jin QQ; Yang YT; Mei J; Hong L; Yao H; Tao F; Li JJ; Liu Y; Zhang L; Chen SX; Chen G; Song Y; Zhou SG Biochem Genet; 2024 Oct; 62(5):3439-3466. PubMed ID: 38108937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]